NASH predicts plasma inflammatory biomarkers independently of visceral fat in men (Q80964439)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369343%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

NASH predicts plasma inflammatory biomarkers independently of visceral fat in men (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369343%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

4

Giuseppe Lippi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369343%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Giovanni Targher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369343%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Lorenzo Bertolini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369343%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Stefano Rodella

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369343%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Massimo Franchini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369343%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Giacomo Zoppini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369343%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Michele Muggeo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369343%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Christopher P Day

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369343%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

27 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369343%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369343%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369343%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

1394-1399

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369343%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369343%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

cites work

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Minireview: Adiposity, Inflammation, and Atherogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Overview of hemostatic factors involved in atherosclerotic cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

PAI-1 and atherothrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Recent concepts in non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Non-alcoholic fatty liver disease: current concepts and management strategies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Plasma PAI-1 levels are increased in patients with nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Visceral fat and liver fat are independent predictors of metabolic risk factors in men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Overproduction of large VLDL particles is driven by increased liver fat content in man.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

The utility of radiological imaging in nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Methods of estimation of visceral fat: advantages of ultrasonography.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Abdominal obesity and fatty liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

31 March 2020

From fat to inflammation

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Long-term follow-up of patients with NAFLD and elevated liver enzymes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Non-alcoholic fatty liver disease and increased risk of cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Metabolic correlates of nonalcoholic fatty liver in women and men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.64

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2008.64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369343%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference